Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Omadacycline on Gut Microbiome
NCT05515562Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omadacycline in Clostridioides difficile infection (CDI), sponsored by Wake Forest University Health Sciences. Started Mar 2023; status: completed.
02
Drugs
omadacycline
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT05515562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05515562.